General Information of Drug (ID: DMTV4HB)

Drug Name
AHCQ
Indication
Disease Entry ICD 11 Status REF
Asthma CA23 Phase 2 [1]
Cross-matching ID
TTD ID
D03MZU

References

1 Aradigm and APT Pharmaceuticals Initiate Phase 2 Clinical Program of Novel Treatment for Asthma